Acerus Pharma | Member of Collaboration Forum | Alliance Management | Business Development | Drug delivery devices

Acerus Pharma acquired all respiratory product pipeline (three generic asthma compounds in Ph I – III, and drug delivery device technology assets (pulmonary & nasal) from Direct-Haler A/S. As former CEO of Direct-Haler A/S and following the industry sale, I was appointed member of the Collaboration Forum between Acerus Pharma and Keldmann Healthcare.

In the Collaboration Forum I had a core role in monitoring and ensuring:
• Continuation of respiratory pipeline product development
• Compliance to commitment of R&D ressources
• Identification of new DDS application opportunities
• Identification of pharma partnering opportunities for development & commercialization
• Exploitation of out-licensing opportunities
• Alliance management of out-licensed technology
• Legal clarifications of rights and obligations in agreements
• Management dialogue for conflict resolution